SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001636050-22-000040
Filing Date
2022-08-11
Accepted
2022-08-11 07:03:14
Documents
44
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q siox-20220630.htm   iXBRL 10-Q 768413
2 EX-31.1 a06302210qsioxexhibit311.htm EX-31.1 11007
3 EX-32.1 a06302210qsioxexhibit321.htm EX-32.1 7138
  Complete submission text file 0001636050-22-000040.txt   3187607

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT siox-20220630.xsd EX-101.SCH 22105
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT siox-20220630_cal.xml EX-101.CAL 32499
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT siox-20220630_def.xml EX-101.DEF 96686
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT siox-20220630_lab.xml EX-101.LAB 319656
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT siox-20220630_pre.xml EX-101.PRE 189869
38 EXTRACTED XBRL INSTANCE DOCUMENT siox-20220630_htm.xml XML 344245
Mailing Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036
Business Address 130 WEST 42ND STREET 26TH FLOOR NEW YORK NY 10036 877-746-4891
Sio Gene Therapies Inc. (Filer) CIK: 0001636050 (see all company filings)

IRS No.: 853863315 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-37418 | Film No.: 221153621
SIC: 2834 Pharmaceutical Preparations